突发性感音神经性聋的MR表现及相关临床特征回顾性分析
该单中心回顾性队列研究纳入2015至2022年因突发性感音神经性聋行内听道MRI的841例患者(929耳),评估耳蜗后病变及临床特征与MRI表现的关系。94.1%的耳无耳蜗后病变,2.7%有相关肿瘤,所有肿瘤均可见于非增强脑池造影序列;纯音平均听阈≥49.5 dB者发现肿瘤或迷路炎的比值比为5.3(P<.001),伴耳鸣者比值比为4.2(P=.02)。作者认为非增强MR方案可能可用于筛查急症病变。
要点
- 纯音平均听阈≥49.5 dB者MRI发现肿瘤或迷路炎的比值比为5.3(P<.001)。
- 伴耳鸣者MRI发现肿瘤或迷路炎的比值比为4.2(P=.02)。
- 所有肿瘤均可见于非增强脑池造影序列,作者认为非增强MR方案可能可用于筛查急症病变。
核心结论
- 多数突发性感音神经性聋患者MRI无耳蜗后病变,仅2.7%有相关肿瘤;高纯音平均听阈和耳鸣可能增加发现可治疗耳蜗后病变的比值比。
研究设计与样本
- 单中心回顾性队列研究,使用2015至2022年患者数据登记库,纳入因突发性感音神经性聋行内听道MRI的患者841例(929耳),平均年龄53.6岁±15.7(标准差)。
关键影像表现/征象
- 874耳(94.1%)MRI无耳蜗后病变。
- 25耳(2.7%)有相关肿瘤,9例肿瘤患者接受手术或放疗。
- 所有肿瘤均可见于非增强脑池造影序列。
- 21耳(2.3%)有提示迷路炎的发现。
- 其他相关发现包括内淋巴管扩大和耳蜗神经细小。
诊断标准与关键数值
- 纯音平均听阈≥49.5 dB者MRI发现肿瘤或迷路炎的比值比为5.3(P<.001)。
- 伴耳鸣者MRI发现肿瘤或迷路炎的比值比为4.2(P=.02)。
- 伴或不伴迷路炎特征的患者之间激素使用无统计学差异(P=.38)。
临床应用与阅片要点
- 作者认为,为筛查急症病变,非增强MR方案可能可行。
- 作者认为,高纯音平均听阈值和耳鸣等临床特征可能增加发现可治疗耳蜗后病变的比值比。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Sudden sensorineural hearing loss (SSNHL) is a dramatic and often frightening condition that benefits from prompt treatment. While most cases of SSNHL are idiopathic, a retrocochlear pathology is expected to account for some presenting cases of SSNHL. This study aims to assess the presence of retrocochlear pathology in SSNHL and ascertain whether clinical features could help determine their presence on MRI.
MATERIALS AND METHODS: A retrospective cohort study was conducted using a patient data registry from 2015 to 2022. Patients who underwent MRI of the internal auditory canals for SSNHL at a single center were included. MRs were reviewed for relevant positive findings and incidental actionable findings. Clinical features recorded included laterality of hearing loss, tinnitus, dizziness, vertigo, and pure tone average (PTA) thresholds from audiograms. Treatment decisions were documented. Exclusion criteria included previous temporal bone pathology, trauma, surgery, or missed MR appointments.
RESULTS: Eight hundred forty-one patients (929 ears; mean age 53.6 years ±15.7 [standard deviation]) were included. MRs showed no retrocochlear pathology in 874 ears (94.1%). Twenty-five ears had relevant tumors (2.7%). Nine patients with tumors underwent surgery or radiation. All tumors were visible on noncontrast cisternographic sequences. Twenty-one ears (2.3%) had findings suggestive of labyrinthitis. Additional relevant findings included enlarged endolymphatic ducts and small cochlear nerves. Patients with a PTA ≥49.5 dB had 5.3 times higher odds of having a tumor or labyrinthitis on MRI (P < .001), and those with tinnitus had 4.2 times higher odds (P = .02). No statistical difference was found in steroid use between patients with or without labyrinthitis features (P = .38).
CONCLUSIONS: Most patients showed no retrocochlear pathology on MRI, with only 2.7% having relevant tumors. To screen for urgent pathology, a noncontrast MR protocol may be feasible. Clinical features such as high PTA values and tinnitus may increase the odds of finding a treatable retrocochlear condition.
引用
- Brennan MJ, Patel SJ, Shin D, et al. Retrospective Review of MR Findings in Sudden Sensorineural Hearing Loss and Associated Clinical Features. AJNR Am J Neuroradiol. 2025. PMID: 41130905. doi:10.3174/ajnr.A8853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。